Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI
NCT06846853Phase 4Recruiting
- Sponsor
- UConn Health
- Start
- Mar 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gadopiclenol, sponsored by UConn Health. Started Mar 2025; status: recruiting.
02
Drugs
gadopiclenol
Beyond the preview
Go deeper on NCT06846853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06846853.